Logo image of BBH

VANECK BIOTECH ETF (BBH) Stock Price, Forecast & Analysis

USA - NASDAQ:BBH - US92189F7261 - ETF

188.619 USD
+0.57 (+0.3%)
Last: 11/17/2025, 4:30:01 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BBH. BBH was compared to 82 industry peers in the Automobile Components industry. Both the profitability and the financial health of BBH get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, BBH is valued expensive at the moment. BBH also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year BBH was profitable.
In the past year BBH had a positive cash flow from operations.
BBH had positive earnings in each of the past 5 years.
BBH had a positive operating cash flow in each of the past 5 years.
BBH Yearly Net Income VS EBIT VS OCF VS FCFBBH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

1.2 Ratios

With a Return On Assets value of 4.39%, BBH perfoms like the industry average, outperforming 45.12% of the companies in the same industry.
BBH's Return On Equity of 8.81% is in line compared to the rest of the industry. BBH outperforms 46.34% of its industry peers.
BBH has a Return On Invested Capital (8.17%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for BBH is in line with the industry average of 8.55%.
Industry RankSector Rank
ROA 4.39%
ROE 8.81%
ROIC 8.17%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
BBH Yearly ROA, ROE, ROICBBH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 5.84%, BBH is in line with its industry, outperforming 48.78% of the companies in the same industry.
In the last couple of years the Profit Margin of BBH has remained more or less at the same level.
Looking at the Operating Margin, with a value of 10.65%, BBH is in line with its industry, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Operating Margin of BBH has remained more or less at the same level.
BBH has a Gross Margin of 27.60%. This is comparable to the rest of the industry: BBH outperforms 41.46% of its industry peers.
In the last couple of years the Gross Margin of BBH has remained more or less at the same level.
Industry RankSector Rank
OM 10.65%
PM (TTM) 5.84%
GM 27.6%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
BBH Yearly Profit, Operating, Gross MarginsBBH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BBH is still creating some value.
Compared to 1 year ago, BBH has less shares outstanding
Compared to 5 years ago, BBH has less shares outstanding
Compared to 1 year ago, BBH has a worse debt to assets ratio.
BBH Yearly Shares OutstandingBBH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BBH Yearly Total Debt VS Total AssetsBBH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

BBH has an Altman-Z score of 5.71. This indicates that BBH is financially healthy and has little risk of bankruptcy at the moment.
BBH's Altman-Z score of 5.71 is amongst the best of the industry. BBH outperforms 89.02% of its industry peers.
The Debt to FCF ratio of BBH is 6.05, which is on the high side as it means it would take BBH, 6.05 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 6.05, BBH is not doing good in the industry: 63.41% of the companies in the same industry are doing better.
BBH has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
BBH's Debt to Equity ratio of 0.32 is on the low side compared to the rest of the industry. BBH is outperformed by 63.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 6.05
Altman-Z 5.71
ROIC/WACC1.04
WACC7.89%
BBH Yearly LT Debt VS Equity VS FCFBBH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

BBH has a Current Ratio of 1.80. This is a normal value and indicates that BBH is financially healthy and should not expect problems in meeting its short term obligations.
BBH has a worse Current ratio (1.80) than 71.95% of its industry peers.
A Quick Ratio of 1.12 indicates that BBH should not have too much problems paying its short term obligations.
BBH has a worse Quick ratio (1.12) than 74.39% of its industry peers.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.12
BBH Yearly Current Assets VS Current LiabilitesBBH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

The earnings per share for BBH have decreased strongly by -18.28% in the last year.
The Earnings Per Share has been growing slightly by 1.64% on average over the past years.
Looking at the last year, BBH shows a decrease in Revenue. The Revenue has decreased by -3.62% in the last year.
Measured over the past years, BBH shows a small growth in Revenue. The Revenue has been growing by 2.41% on average per year.
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%

3.2 Future

The Earnings Per Share is expected to grow by 11.26% on average over the next years. This is quite good.
Based on estimates for the next years, BBH will show a small growth in Revenue. The Revenue will grow by 2.85% on average per year.
EPS Next Y0.74%
EPS Next 2Y8.86%
EPS Next 3Y11.26%
EPS Next 5YN/A
Revenue Next Year-4.87%
Revenue Next 2Y-1.29%
Revenue Next 3Y0.41%
Revenue Next 5Y2.85%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BBH Yearly Revenue VS EstimatesBBH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
BBH Yearly EPS VS EstimatesBBH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

0

4. Valuation

4.1 Price/Earnings Ratio

BBH is valuated quite expensively with a Price/Earnings ratio of 73.97.
Based on the Price/Earnings ratio, BBH is valued a bit more expensive than 76.83% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.56, BBH is valued quite expensively.
Based on the Price/Forward Earnings ratio of 52.15, the valuation of BBH can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BBH indicates a slightly more expensive valuation: BBH is more expensive than 79.27% of the companies listed in the same industry.
BBH is valuated expensively when we compare the Price/Forward Earnings ratio to 34.62, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 73.97
Fwd PE 52.15
BBH Price Earnings VS Forward Price EarningsBBH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

76.83% of the companies in the same industry are cheaper than BBH, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BBH indicates a slightly more expensive valuation: BBH is more expensive than 73.17% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 92.16
EV/EBITDA 24.31
BBH Per share dataBBH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)100.02
PEG (5Y)45.02
EPS Next 2Y8.86%
EPS Next 3Y11.26%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.77%, BBH is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.20, BBH pays a better dividend. On top of this BBH pays more dividend than 97.56% of the companies listed in the same industry.
BBH's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 4.77%

5.2 History

On average, the dividend of BBH grows each year by 7.84%, which is quite nice.
BBH has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of BBH decreased recently.
Dividend Growth(5Y)7.84%
Div Incr Years1
Div Non Decr Years1
BBH Yearly Dividends per shareBBH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8 1

5.3 Sustainability

BBH pays out 62.40% of its income as dividend. This is not a sustainable payout ratio.
BBH's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP62.4%
EPS Next 2Y8.86%
EPS Next 3Y11.26%
BBH Yearly Income VS Free CF VS DividendBBH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B
BBH Dividend Payout.BBH Dividend Payout, showing the Payout Ratio.BBH Dividend Payout.PayoutRetained Earnings

VANECK BIOTECH ETF

NASDAQ:BBH (11/17/2025, 4:30:01 PM)

188.619

+0.57 (+0.3%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)02-22 2026-02-22/amc
Inst Owners46.28%
Inst Owner Change-13.74%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap133.12B
Revenue(TTM)26.74B
Net Income(TTM)1.56B
Analysts79.17
Price Target205.58 (8.99%)
Short Float %0%
Short Ratio1.43
Dividend
Industry RankSector Rank
Dividend Yield 4.77%
Yearly Dividend1.58
Dividend Growth(5Y)7.84%
DP62.4%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.9%
PT rev (3m)1.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-16.83%
EPS NY rev (3m)-25.57%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.93%
Revenue NY rev (3m)-3.52%
Valuation
Industry RankSector Rank
PE 73.97
Fwd PE 52.15
P/S 4.27
P/FCF 92.16
P/OCF 33.78
P/B 6.45
P/tB 8.76
EV/EBITDA 24.31
EPS(TTM)2.55
EY1.35%
EPS(NY)3.62
Fwd EY1.92%
FCF(TTM)2.05
FCFY1.09%
OCF(TTM)5.58
OCFY2.96%
SpS44.13
BVpS29.25
TBVpS21.53
PEG (NY)100.02
PEG (5Y)45.02
Graham Number40.97
Profitability
Industry RankSector Rank
ROA 4.39%
ROE 8.81%
ROCE 10.41%
ROIC 8.17%
ROICexc 9.37%
ROICexgc 11.66%
OM 10.65%
PM (TTM) 5.84%
GM 27.6%
FCFM 4.64%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
ROICexc(3y)10.45%
ROICexc(5y)9.86%
ROICexgc(3y)12.91%
ROICexgc(5y)12.2%
ROCE(3y)11.87%
ROCE(5y)10.97%
ROICexgc growth 3Y-1.17%
ROICexgc growth 5Y0.57%
ROICexc growth 3Y-1.78%
ROICexc growth 5Y0.45%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 6.05
Debt/EBITDA 1.17
Cap/Depr 107.96%
Cap/Sales 8.01%
Interest Coverage 9.96
Cash Conversion 70%
Profit Quality 79.44%
Current Ratio 1.8
Quick Ratio 1.12
Altman-Z 5.71
F-Score5
WACC7.89%
ROIC/WACC1.04
Cap/Depr(3y)113.8%
Cap/Depr(5y)101.88%
Cap/Sales(3y)7.8%
Cap/Sales(5y)7.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
EPS Next Y0.74%
EPS Next 2Y8.86%
EPS Next 3Y11.26%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%
Revenue Next Year-4.87%
Revenue Next 2Y-1.29%
Revenue Next 3Y0.41%
Revenue Next 5Y2.85%
EBIT growth 1Y-17.5%
EBIT growth 3Y1.98%
EBIT growth 5Y1.14%
EBIT Next Year59.12%
EBIT Next 3Y22.78%
EBIT Next 5Y17.06%
FCF growth 1Y-20.46%
FCF growth 3Y21.5%
FCF growth 5Y7.22%
OCF growth 1Y-10.1%
OCF growth 3Y14.27%
OCF growth 5Y5.48%

VANECK BIOTECH ETF / BBH FAQ

What does VANECK BIOTECH ETF do?

Compagnie Générale des Établissements Michelin SCA engages in the manufacture, distribution and sale of tires. The company is headquartered in Clermont-Ferrand, Auvergne-Rhone-Alpes and currently employs 127,500 full-time employees. The firm operates through three segments: Automotive, Road Transportation and Specialty Businesses. Automotive, which comprises the business lines Automotive business to customers (B2C) Global Brands, Automotive B2C Regional Brands, Automotive Original Equipment and Mobility Experiences. Road Transportation comprises the business lines Long Distance Transportation, Urban Transportation and Services & Solutions. Specialty Businesses comprises the business lines Mining, Off-Highway Transportation, Two-Wheel, Aircraft and High-Tech Materials. The company provides different kind of tires and related products and services through a dealership network. Its service offering includes truck driver assistance with Michelin Euro Assist, fleet tire advice, maintenance and management services and mobility assistance services, among others. Additionally, it provides branded lifestyle products and high-tech materials.


Can you provide the latest stock price for VANECK BIOTECH ETF?

The current stock price of BBH is 188.619 USD. The price increased by 0.3% in the last trading session.


How is the ChartMill rating for VANECK BIOTECH ETF?

BBH has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Which stock exchange lists BBH stock?

BBH stock is listed on the Nasdaq exchange.